Marion Jaffrelot

An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes

Marion Jaffrelot, Nadim Farés, Anne Cécile Brunac et al. · Modern Pathology · 2021 · 59 citations · Full text

Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study

Emily Alouani, M. Mercier, Clémence Flecchia et al. · ESMO Open · 2023 · 26 citations · Full text

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers

Camille Evrard, Stéphane Messina, David Sefrioui et al. · International Journal of Molecular Sciences · 2022 · 24 citations · Full text

Immunology, Immunoediting, Pathology +17

CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma

Anne‐Cécile Brunac, Joanna Fourquet, Gaëlle Pérot et al. · Modern Pathology · 2022 · 12 citations · Full text

<scp>FOLFIRI</scp> plus <scp>BEvacizumab</scp> or <scp>aFLIbercept</scp> after <scp>FOLFOX</scp>‐bevacizumab failure for <scp>COlorectal</scp> cancer (<scp>BEFLICO</scp>): An <scp>AGEO</scp> multicenter study

Cécile Torregrosa, Simon Pernot, Pauline Vaflard et al. · International Journal of Cancer · 2022 · 11 citations · Full text